Member Info for LBview

Apologies, typo - 258m approx.

And even now the shares in issue are low @ 280 so yes, it does move in either direction quickly

Agree , this price is the lowest since I started buying in 2021 - approx. this time of the year in 2021 and 2022 I was buying @ 10p+ and 15p+ respectively, so when I said a few months ago when I was buying @ 5p and below that it was the lowest I had seen it, no joke

Well that could be a number of things, but if they bought just recently under .8 then they have made a decent profit this morning

31st July RNS - "On track to produce its first crop for commercial sale, under its existing off-take agreements, during Q2 of the Company's fiscal year".

Same quote in the 6th July RNS

Illegal to say anything untrue in an RNS, if this was not the case they would have had to release an RNS saying so

6th July RNS

“The Company previously secured a number of unused post harvest area equipment, as part of the final aspects of completion of its facility which has provided significant cost savings. The Company is on track to produce its first harvest for commercial sale, under its existing off-take agreements, in line with its previous announcements, within Q2 of the Company's fiscal year”

Confirmed again in the 31st July RNS - Annual Report

Ridiculous price this morning - was buying at the start of this company at treble these prices and thought it fair value then - topped up a little more

Also, as per the 31st July RNS, they have successfully received a European Union ("EU") grant via the EU Horizon Europe project of EUR €304,425

Hellenic Dynamics' is the sole medicinal cannabis cultivator in the research consortium that was awarded the Reliable Artificial Intelligence and Data Optimisation project of the EU Horizon Europe grant.

This successful grant application will further assist Hellenic Dynamics' cultivation strategy by utilising AI in best cultivation methodology to provide consistent medical cannabis products to the Company's licensed distributors.

I have been here since the start and rarely (when I have tried to buy) has it been so difficult to do so - All morning it was hard to get a live price, you had to call the broker or just let your order go and cross your fingers - just done it again - ???? - really easy to sell all of them though

Agree it is undervalued, something quietly going on, no real chat/ramp/de-ramp even though it is in the top 5 risers today - crop news will be the next RNS I guess and were were told 'late summer'? - maybe something due?, we all know why we continue to hold onto this share

GLA

I see Ria is here, she was on one of my other shares HELD not long ago - I guess when crop news hits she will be aggravating us over there again, she is not disruptive but it can get a bit tiresome

When will this share hit the radar?, still here from the SPAC days, just keep chipping away at my average at these rock bottom prices

Waffle is right, my personal opinion is to buy when I can on the dips, have done so again this morning

GLA

Looked into this one last night - Bought this morning, right or wrong still only just over 52m in issue !

Good morning

We are right in the middle of drilling season in Australia - Yes, you are correct it started to fall after reaching approx. 18p, I was buying also at this time, August 2022 it was in the region of 15p+ - Drilling season's sweet spot in Australia (spring) is September to October (better weather for drilling ), of course it dropped off after approx. November last year as drilling had shut down

From the 12th June RNS:

"A special dividend of 0.20p per ordinary share will be paid on 14 July 2023 to shareholders on the register as at 23 June 2023. The associated ex-dividend date will be 22 June 2023".

The appointment of Katherine Fleming, MOU with ELCO-DIMITRA, appointment of Development Team, Business Update, the trend for all recent relevant RNS's would seem to be @ 7am

To repeat; please go to their website and look at 'facility'

"The facility has been designed to produce the highest quality dried medical cannabis flowers and extracts with one of the lowest costs of production in Europe. This is underpinned by access to some of the most competitive utilities in Europe and the site having its own dedicated water supply by way of a number of underground reservoirs. Based near the town of Kilkis, Hellenic Dynamics is also able to leverage a large skilled local workforce, bringing much needed employment to the area.

Previously a United Nations military facility, the site consists of 14 buildings and uniquely a number of over ground bunkers where initial plant cultivation is housed. Construction is also due to begin on a 10,000 square meter fully enclosed greenhouse, which Hellenic intents to use via a phased approach utilizing revues to expand overall cultivation area.

All dried flowers to be produced in phase one of operations have been presold to licensed distributors – initially in Europe’s largest medical cannabis market of Germany with further distribution lines into other European markets underway".

And just for good measure, they appointed Katherine Fleming to the Advisory Board:

"27 March 2023: Hellenic Dynamics plc (LSE: HELD) a medical cannabis cultivation company, is pleased to announce the appointment of Katherine Fleming to its Advisory Board. Katherine is currently the President and CEO of the J. Paul Getty Trust, the international cultural and philanthropic institution, overseeing its 1,500 employees and US$8.5 billion endowment fund" - Please read the entire RNS, if you wish

London, 27 March 2023: Hellenic Dynamics plc (LSE: HELD) a medical cannabis cultivation company, is pleased to announce the appointment of Katherine Fleming to its Advisory Board. Katherine is currently the President and CEO of the J. Paul Getty Trust, the international cultural and philanthropic institution, overseeing its 1,500 employees and US$8.5 billion endowment fund.

And this will be the very beginning of news, etc:

RNS 22nd March - MOU with ELGO-DIMITRA, a few paragraphs here but please read the entire RNS:

Hellenic Dynamics believes that by jointly researching medical cannabis flowers with ELGO-DIMITRA at the Company's facility, Hellenic may be able to exploit the joint research in seeking registration of its specific medical cannabis tetrahydrocannabinol ("THC") dominant genetics onto the Greek national genetics database. This in turn could lead to Hellenic Dynamics in future gaining Intellectual Property ("IP") protection on certain genetics, which the Company believes could be enforceable across Europe.

The ambition of Hellenic Dynamics remains to define certain THC dominant medical cannabis flowers cultivated at the Company's production facility in Greece against specific pain and other indicators in patients. This cooperation agreement with ELGO-DIMITRA could add significant upside to the Company and help accelerate its ambition if efficacy in patients can be identified.

This MoU, is in addition to Hellenic Dynamics's near-term plan to be the dominant cultivator of competitively priced THC dominant medical cannabis flowers in Europe, where the rapidly growing medical cannabis markets are expected to reach €43.3 billion per annum by 2027.